BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $398,119 | -48.4% | 10,549 | -37.7% | 0.09% | -46.7% |
| Q2 2023 | $771,513 | +4.5% | 16,934 | -7.0% | 0.17% | 0.0% |
| Q1 2023 | $738,638 | -28.7% | 18,211 | -10.3% | 0.17% | -31.6% |
| Q4 2022 | $1,035,252 | -14.5% | 20,311 | -9.6% | 0.25% | -17.4% |
| Q3 2022 | $1,211,000 | -16.9% | 22,476 | -1.0% | 0.30% | -11.3% |
| Q2 2022 | $1,458,000 | -17.2% | 22,706 | 0.0% | 0.34% | -1.7% |
| Q1 2022 | $1,761,000 | -9.6% | 22,706 | 0.0% | 0.34% | -5.8% |
| Q4 2021 | $1,949,000 | +1.7% | 22,706 | -4.7% | 0.36% | -3.4% |
| Q3 2021 | $1,917,000 | -26.0% | 23,831 | -25.9% | 0.38% | -23.4% |
| Q2 2021 | $2,589,000 | -4.6% | 32,165 | 0.0% | 0.49% | -11.0% |
| Q1 2021 | $2,713,000 | +5.1% | 32,165 | 0.0% | 0.55% | -1.6% |
| Q4 2020 | $2,581,000 | -1.8% | 32,165 | -1.5% | 0.56% | -11.9% |
| Q3 2020 | $2,627,000 | -7.3% | 32,665 | -0.8% | 0.64% | -14.7% |
| Q2 2020 | $2,834,000 | +5.9% | 32,915 | -0.2% | 0.75% | -7.9% |
| Q1 2020 | $2,676,000 | -3.1% | 32,965 | -0.3% | 0.81% | +21.6% |
| Q4 2019 | $2,763,000 | -4.4% | 33,048 | 0.0% | 0.67% | -10.5% |
| Q3 2019 | $2,891,000 | +6.8% | 33,048 | 0.0% | 0.75% | +4.6% |
| Q2 2019 | $2,707,000 | -1.5% | 33,048 | -2.2% | 0.71% | -8.5% |
| Q1 2019 | $2,749,000 | +9.7% | 33,803 | -11.2% | 0.78% | -5.0% |
| Q4 2018 | $2,507,000 | -18.7% | 38,083 | -4.7% | 0.82% | -3.0% |
| Q3 2018 | $3,082,000 | +2.4% | 39,978 | -1.9% | 0.84% | -6.1% |
| Q2 2018 | $3,009,000 | +7.6% | 40,751 | -5.2% | 0.90% | -3.1% |
| Q1 2018 | $2,797,000 | -0.2% | 43,001 | -0.8% | 0.93% | +2.7% |
| Q4 2017 | $2,802,000 | +3.0% | 43,341 | 0.0% | 0.90% | -3.5% |
| Q3 2017 | $2,720,000 | +4.4% | 43,341 | +0.7% | 0.94% | -2.3% |
| Q2 2017 | $2,605,000 | +13.1% | 43,026 | -2.4% | 0.96% | +6.9% |
| Q1 2017 | $2,304,000 | +18.3% | 44,103 | +0.4% | 0.90% | +10.2% |
| Q4 2016 | $1,947,000 | -2.2% | 43,918 | +5.0% | 0.82% | -9.1% |
| Q3 2016 | $1,991,000 | +5.3% | 41,818 | 0.0% | 0.90% | +4.9% |
| Q2 2016 | $1,891,000 | +9.6% | 41,818 | 0.0% | 0.86% | +2.3% |
| Q1 2016 | $1,725,000 | +2.9% | 41,818 | -4.9% | 0.84% | +2.3% |
| Q4 2015 | $1,677,000 | – | 43,968 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |